Annual CFI
$71.84 M
+$533.18 M+115.57%
31 December 2023
Summary:
Beam Therapeutics annual cash flow from investing activities is currently $71.84 million, with the most recent change of +$533.18 million (+115.57%) on 31 December 2023. During the last 3 years, it has risen by +$171.96 million (+171.75%). BEAM annual CFI is now at all-time high.BEAM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$24.70 M
-$62.80 M-71.77%
30 September 2024
Summary:
Beam Therapeutics quarterly cash flow from investing activities is currently $24.70 million, with the most recent change of -$62.80 million (-71.77%) on 30 September 2024. Over the past year, it has increased by +$34.93 million (+341.43%). BEAM quarterly CFI is now -78.23% below its all-time high of $113.44 million, reached on 31 December 2022.BEAM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$156.83 M
+$34.93 M+28.65%
30 September 2024
Summary:
Beam Therapeutics TTM cash flow from investing activities is currently $156.83 million, with the most recent change of +$34.93 million (+28.65%) on 30 September 2024. Over the past year, it has increased by +$69.65 million (+79.89%). BEAM TTM CFI is now at all-time high.BEAM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +115.6% | +341.4% | +79.9% |
| 3 y3 years | +171.8% | -67.5% | +152.6% |
| 5 y5 years | +635.2% | +73.8% | +288.4% |
BEAM Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +115.6% | -78.2% | +104.6% | at high | +124.0% |
| 5 y | 5 years | at high | +115.6% | -78.2% | +104.6% | at high | +124.0% |
| alltime | all time | at high | +115.6% | -78.2% | +104.6% | at high | +124.0% |
Beam Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.70 M(-71.8%) | $156.83 M(+28.7%) |
| June 2024 | - | $87.49 M(-263.6%) | $121.90 M(-1822.9%) |
| Mar 2024 | - | -$53.46 M(-154.5%) | -$7.08 M(-109.8%) |
| Dec 2023 | $71.84 M(-115.6%) | $98.10 M(-1058.9%) | $71.84 M(-17.6%) |
| Sept 2023 | - | -$10.23 M(-75.3%) | $87.18 M(+42.4%) |
| June 2023 | - | -$41.48 M(-263.0%) | $61.24 M(-39.6%) |
| Mar 2023 | - | $25.45 M(-77.6%) | $101.45 M(-122.0%) |
| Dec 2022 | -$461.34 M(+56.8%) | $113.44 M(-413.6%) | -$461.34 M(-29.3%) |
| Sept 2022 | - | -$36.17 M(+2766.4%) | -$652.27 M(+20.8%) |
| June 2022 | - | -$1.26 M(-99.8%) | -$539.98 M(-2.2%) |
| Mar 2022 | - | -$537.34 M(+593.4%) | -$551.86 M(+87.6%) |
| Dec 2021 | -$294.14 M | -$77.50 M(-201.8%) | -$294.14 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $76.11 M(-679.4%) | -$298.07 M(-12.1%) |
| June 2021 | - | -$13.14 M(-95.3%) | -$338.96 M(+11.9%) |
| Mar 2021 | - | -$279.63 M(+243.4%) | -$302.96 M(+202.6%) |
| Dec 2020 | -$100.12 M(+50.2%) | -$81.43 M(-331.1%) | -$100.12 M(+4585.2%) |
| Sept 2020 | - | $35.23 M(+54.0%) | -$2.14 M(-90.8%) |
| June 2020 | - | $22.87 M(-129.8%) | -$23.15 M(-83.6%) |
| Mar 2020 | - | -$76.79 M(-563.7%) | -$141.10 M(+111.7%) |
| Dec 2019 | -$66.66 M(+396.6%) | $16.56 M(+16.5%) | -$66.66 M(-19.9%) |
| Sept 2019 | - | $14.21 M(-114.9%) | -$83.22 M(-14.6%) |
| June 2019 | - | -$95.08 M(+3939.0%) | -$97.43 M(+4039.0%) |
| Mar 2019 | - | -$2.35 M | -$2.35 M |
| Dec 2018 | -$13.42 M | - | - |
FAQ
- What is Beam Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Beam Therapeutics?
- What is Beam Therapeutics annual CFI year-on-year change?
- What is Beam Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Beam Therapeutics?
- What is Beam Therapeutics quarterly CFI year-on-year change?
- What is Beam Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Beam Therapeutics?
- What is Beam Therapeutics TTM CFI year-on-year change?
What is Beam Therapeutics annual cash flow from investing activities?
The current annual CFI of BEAM is $71.84 M
What is the all time high annual CFI for Beam Therapeutics?
Beam Therapeutics all-time high annual cash flow from investing activities is $71.84 M
What is Beam Therapeutics annual CFI year-on-year change?
Over the past year, BEAM annual cash flow from investing activities has changed by +$533.18 M (+115.57%)
What is Beam Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BEAM is $24.70 M
What is the all time high quarterly CFI for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash flow from investing activities is $113.44 M
What is Beam Therapeutics quarterly CFI year-on-year change?
Over the past year, BEAM quarterly cash flow from investing activities has changed by +$34.93 M (+341.43%)
What is Beam Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BEAM is $156.83 M
What is the all time high TTM CFI for Beam Therapeutics?
Beam Therapeutics all-time high TTM cash flow from investing activities is $156.83 M
What is Beam Therapeutics TTM CFI year-on-year change?
Over the past year, BEAM TTM cash flow from investing activities has changed by +$69.65 M (+79.89%)